377 related articles for article (PubMed ID: 16293781)
1. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.
Ménard J; Payette H; Baillargeon JP; Maheux P; Lepage S; Tessier D; Ardilouze JL
CMAJ; 2005 Dec; 173(12):1457-66. PubMed ID: 16293781
[TBL] [Abstract][Full Text] [Related]
2. Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.
Brinton EA; Ballantyne CM; Bays HE; Kastelein JJ; Braeckman RA; Soni PN
Cardiovasc Diabetol; 2013 Jul; 12():100. PubMed ID: 23835245
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
4. Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus.
Guo LX; Pan Q; Wang XX; Li H; Zhang LN; Chi JM; Wang Y
Chin Med J (Engl); 2008 Apr; 121(8):687-90. PubMed ID: 18701019
[TBL] [Abstract][Full Text] [Related]
5. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
[TBL] [Abstract][Full Text] [Related]
6. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
7. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
8. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
[TBL] [Abstract][Full Text] [Related]
9. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
Yale JF; Valiquett TR; Ghazzi MN; Owens-Grillo JK; Whitcomb RW; Foyt HL
Ann Intern Med; 2001 May; 134(9 Pt 1):737-45. PubMed ID: 11329231
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
[TBL] [Abstract][Full Text] [Related]
12. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
Davis TM; Cull CA; Holman RR;
Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
[TBL] [Abstract][Full Text] [Related]
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in type 2 diabetes patients under intensive multitherapy.
Ménard J; Payette H; Dubuc N; Baillargeon JP; Maheux P; Ardilouze JL
Diabetes Metab; 2007 Feb; 33(1):54-60. PubMed ID: 17258926
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of standardized nursing care plans to achieve A1C, blood pressure, and LDL-C goals among people with poorly controlled type 2 diabetes mellitus at baseline: four-year follow-up study.
Cárdenas-Valladolid J; López-de Andrés A; Jiménez-García R; de Dios-Duarte MJ; Gómez-Campelo P; de Burgos-Lunar C; San Andrés-Rebollo FJ; Abánades-Herranz JC; Salinero-Fort MA
BMC Fam Pract; 2018 Jul; 19(1):125. PubMed ID: 30041600
[TBL] [Abstract][Full Text] [Related]
16. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin on cholesterol synthesis in type II diabetes patients.
Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
Sherrill CH; Pentecost A; Wood EE
J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
[TBL] [Abstract][Full Text] [Related]
19. The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study.
Cai X; Hu D; Pan C; Li G; Lu J; Ji Q; Su B; Tian H; Qu S; Weng J; Zhang D; Xu J; Ji L
Sci Rep; 2019 May; 9(1):7709. PubMed ID: 31118445
[TBL] [Abstract][Full Text] [Related]
20. Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
Lewin AJ; Kipnes MS; Meneghini LF; Plotkin DJ; Perevozskaya IT; Shah S; Maccubbin DL; Mitchel YB; Tobert JA;
Clin Ther; 2004 Mar; 26(3):379-89. PubMed ID: 15110130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
